Synthetic Hype
By Jonathan Kahn,
Biopolitical Times guest contributor
| 12. 27. 2010
I've been thinking lately about the current excitement over the promise and potential of synthetic biology. The basic idea of synthetic biology is to make biology more like engineering, creating standardized biological "parts" that can be combined to redesign existing biological systems or create entirely new ones that do not already exist in the natural world. It is aptly represented by the concept of "biobricks," a
trademarked term describing "standard biological parts [that] a synthetic biologist or biological engineer can [use to] program living organisms in the same way a computer scientist can program a computer."
I am concerned because this seems to be the latest in a long line of grand promises that have accompanied demands for resources (both monetary and intellectual) for successive major biotechnological undertakings over the past twenty years. Each of these undertakings has been worthy in its own right but none has, as yet, come anywhere near to realizing the extravagant claims made by its initial promoters. Modern developments in biotechnology have been driven, in part, by an ever receding horizon of promise. Many scholars...
Related Articles
By Andrew Gregory, The Guardian | 01.11.2026
Google has removed some of its artificial intelligence health summaries after a Guardian investigation found people were being put at risk of harm by false and misleading information.
The company has said its AI Overviews, which use generative AI to...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Sarah A. Topol, The New York Times Magazine | 12.14.2025
The women in House 3 rarely had a chance to speak to the women in House 5, but when they did, the things they heard scared them. They didn’t actually know where House 5 was, only that it was huge...
By Mario Aguilar, Stat | 12.01.2025
The Food and Drug Administration on Monday announced plans to offer its employees a broader set of artificial intelligence tools to use in premarket reviews and for other purposes amid persistent concerns that the technology can behave unpredictably.
The agency...